Latest news

Commercial

Building on a “centuries-old bond,” Singapore establishes a biotech-focused Boston hub

With the original site of the international hotel chain having been established in Singapore almost 140 years ago, the...
Clinical

The Definium LSD medication wins another crucial anxiety study, making it 3 for 3

Definium Therapeutics has once again won in a phase 3 trial of its LSD formula, this time for the...
Insights

Top 10 AI Models Used in Drug Design

Executive Summary Artificial intelligence is changing drug design by enabling researchers to model biological structures, predict molecular interactions, generate new...
Insights

Why Multi-Omics Is Becoming a Strategic Priority in Life Sciences

Executive Summary Modern life sciences research is generating more biological data than ever before. Genomics has transformed the understanding of DNA,...
Regulatory

The FDA halts enrollment in critical trials for the troubled epilepsy medication, dealing another blow to Biohaven

Biohaven stock fell more than 13% in premarket trading...
Insights

Remote Monitoring in Clinical Trials

Executive Summary Clinical trials are becoming increasingly decentralized, data-driven, and...
Insights

The Rise of In Silico Clinical Trials

Executive Summary Clinical trials remain one of the most important and expensive stages of drug development. They provide essential evidence...
Clinical

Novo Reports Late-Stage Semaglutide Trial Results in Children With Obesity

Novo Nordisk said on Monday that its late-stage STEP Young trial found that 40.4% of children aged 6 to...
Clinical

After the most recent phase 2 failure, Evommune gives up on using an MRGPRX2 antagonist to cure itching

Evommune's G-protein coupled receptor X2 (MRGPRX2) antagonist has failed another phase 2 trial, ending the biotech's final chance at...
Clinical

Beeline Afimetoran Meets Phase 2 Endpoint in Systemic Lupus Erythematosus

Beeline Medicines has reported positive topline findings from a...
Insights

Top 10 AI Risks Every Pharmaceutical Executive Should Understand

Executive Summary Artificial intelligence (AI) is becoming embedded across pharmaceutical...
Insights

The Rise of Autonomous Laboratories

Executive Summary Pharmaceutical research is entering a new phase of automation. For decades, laboratories have adopted individual technologies to automate repetitive...
Clinical

Phase 3 of Ultragenyx fails to plot “significant expense reductions” using the Angelman test

Ultragenyx had been on a roll with its recent FDA approval of Genglycos, but the company has finally been...
Clinical

Following the cancelation of more phase 3 trials, Novo’s blockbuster aspirations for the CKD program decline

Novo's:The prospects for ziltivekimab, a drug that analysts had previously predicted would be a blockbuster, have been further damaged...
Commercial

Celltrion Healthcare introduces a biosimilar version of Humira called Yuflyma, in the US

Celltrion Healthcare, a biopharmaceutical company based in South Korea,...
Commercial

Gilead Explores Triple-Target T-Cell Engagers in over $1.5B Merus Partnership

Bispecific T-cell engagers are gaining prominence in oncology, yet...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Suki announced Tuesday the release of Suki Dictation, an artificial intelligence-powered dictation solution designed...
Editorial Team -

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

Healthcare-related infections remain a persistent challenge for hospitals, affecting roughly one in every 40...
Editorial Team -

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

The U.S. Food and Drug Administration (FDA) granted Johnson & Johnson De Novo clearance...
Editorial Team -

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Regulatory

Clinical

The Definium LSD medication wins another crucial anxiety study, making it 3 for 3

Definium Therapeutics has once again won in a phase...
Insights

Top 10 AI Models Used in Drug Design

Executive Summary Artificial intelligence is changing drug design by enabling...
Insights

Why Multi-Omics Is Becoming a Strategic Priority in Life Sciences

Executive Summary Modern life sciences research is generating more biological...
Clinical

AbbVie’s Phase 3 Victory Opens Door For Qulipta Expansion

AbbVie has cleared another hurdle in its effort to...

Research & Development

Market Access

Manufacturing

Daiichi Revises ADC Supply Plans After Changes in Cancer Drug Demand Forecasts

Daiichi Sankyo said changes in projected demand for several...
Manufacturing

Lilly Adds $4.5 Billion to Indiana Manufacturing Expansion, Total U.S. Commitments Exceed $50 Billion

Eli Lilly has announced an additional $4.5 billion investment...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Manufacturing

Aura Biosciences Refocuses on Ocular Oncology Programs and Cuts Workforce by 20%

Aura Biosciences is restructuring its operations under recently appointed...
Editorial Team -
Insights

Top 10 AI Models Used in Drug Design

Executive Summary Artificial intelligence is changing drug design by enabling...
Editorial Team -